Seuwen K, Magnaldo I, Kobilka B K, Caron M G, Regan J W, Lefkowitz R J, Pouysségur J
Centre de Biochimie du CNRS, Faculté des Sciences, Université de Nice, France.
Cell Regul. 1990 May;1(6):445-51. doi: 10.1091/mbc.1.6.445.
To test the hypothesis that agents activating receptors negatively coupled to adenylyl cyclase (AC) can stimulate cell proliferation, we have expressed a human alpha 2-adrenergic receptor (alpha 2-C10) in CCL39 cells and studied the effects of alpha 2-agonists on reinitiation of DNA synthesis in quiescent cells. We report that the alpha 2-agonists epinephrine and clonidine stimulate [3H]-thymidine incorporation in synergy with fibroblast growth factor and that the alpha 2-antagonist yohimbine efficiently inhibits this response. Epinephrine- and clonidine-stimulated DNA synthesis is completely blocked by pertussis toxin and correlates well with the inhibition of prostaglandin E1-stimulated AC. Thus, their action closely resembles the action of serotonin in the same cell system, which is mediated through 5-HT1b receptors. In fact, serotonin- and epinephrine-stimulated DNA synthesis reinitiation is not additive, suggesting that both agents act through a common pathway. Interestingly, alpha 2-agonists also induced a moderate release of inositol phosphates, indicating that alpha 2-adrenergic receptors can interact both with the AC and phospholipase C messenger system. Activation of phosphoinositide (PI) turnover by epinephrine leads to a significant stimulation of Na+/H+ exchange but is insufficient to trigger a mitogenic response in CCL39 cells, as will be discussed. We found no evidence for epinephrine-induced activation of Na+/H+ exchange by a mechanism independent of PI breakdown.Our data show that alpha 2-adrenergic receptors can play a role in the regulation of cell proliferation in an appropriate context; also, the data support the hypothesis that receptors negatively coupled to AC must be taken into account as mediators of growth factor action in fibroblasts, in particular when activated in parallel with receptor tyrosine kinases.
为了验证激活与腺苷酸环化酶(AC)负偶联受体的药物可刺激细胞增殖这一假说,我们在CCL39细胞中表达了人α2 - 肾上腺素能受体(α2 - C10),并研究了α2 - 激动剂对静止细胞中DNA合成重新启动的影响。我们报告称,α2 - 激动剂肾上腺素和可乐定与成纤维细胞生长因子协同刺激[3H] - 胸苷掺入,且α2 - 拮抗剂育亨宾能有效抑制这种反应。肾上腺素和可乐定刺激的DNA合成被百日咳毒素完全阻断,并且与前列腺素E1刺激的AC的抑制密切相关。因此,它们的作用与同一细胞系统中5 - 羟色胺的作用非常相似,后者是通过5 - HT1b受体介导的。事实上,5 - 羟色胺和肾上腺素刺激的DNA合成重新启动并无叠加效应,这表明两种药物通过共同途径发挥作用。有趣的是,α2 - 激动剂还诱导了适度的肌醇磷酸释放,表明α2 - 肾上腺素能受体可同时与AC和磷脂酶C信使系统相互作用。肾上腺素激活磷酸肌醇(PI)周转会显著刺激Na+/H+交换,但不足以在CCL39细胞中引发促有丝分裂反应,这将在后面讨论。我们没有发现肾上腺素通过独立于PI分解的机制诱导Na+/H+交换激活的证据。我们的数据表明,α2 - 肾上腺素能受体在适当的环境中可参与细胞增殖的调节;此外,数据支持这样的假说,即与AC负偶联的受体必须被视为成纤维细胞中生长因子作用的介质,特别是当与受体酪氨酸激酶同时被激活时。